Insider · CIK 0001287920
Gail Boudreaux
Files at TGT (TARGET CORP), ELV (Elevance Health, Inc.). First filing Jul 18, 2025, latest Jul 18, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ELV: Elevance Health, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 71Notable | ELVbuy Elevance Health, Inc. | $2.4M 8,500 shares | +6% | 0% from low-49% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 18, 2025 | ELV Elevance Health, Inc. | POpen-market purchase Common Stock | +2,334 | $286.07 | $668k | 144,854 | Jul 18, 2025 |
| Jul 18, 2025 | ELV Elevance Health, Inc. | POpen-market purchase Common Stock | +5,116 | $287.12 | $1.5M | 149,970 | Jul 18, 2025 |
| Jul 18, 2025 | ELV Elevance Health, Inc. | POpen-market purchase Common Stock | +1,050 | $287.96 | $302k | 151,020 | Jul 18, 2025 |
| Mar 12, 2025 | TGT TARGET CORP | AGrant or award Common Stock | +2,946 | $0.00 | $0 | 9,067 | Mar 14, 2025 |
| Mar 3, 2025 | ELV Elevance Health, Inc. | FTax withholding Common Stock | -10,396 | $395.50 | $4.1M | 116,313 | Mar 5, 2025 |
| Mar 3, 2025 | ELV Elevance Health, Inc. | AGrant or award Common Stock | +10,620 | $0.00 | $0 | 126,933 | Mar 5, 2025 |
| Mar 3, 2025 | ELV Elevance Health, Inc. | AGrant or award Common Stock | +15,587 | $0.00 | $0 | 142,520 | Mar 5, 2025 |
| Mar 3, 2025 | ELV Elevance Health, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +40,429 | $0.00 | $0 | 40,429 | Mar 5, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.